Home > Press > Bio Nano Consulting (BNC) strengthens team on back of increasing business
Abstract:
Bio Nano Consulting (BNC), the specialist bionanotechnology product development consultancy, has appointed Mike Fisher PhD as Business Development Director and to manage a major new UK Government contract. Until recently Dr Fisher was with UKTI in Boston, USA as the British Government's North American advisor on life sciences.
A medicinal chemist with over ten years postdoctoral experience in research, project management and consulting, Dr Fisher helped develop the biotech cluster in the Northwest of England and became a founder of the Northwest Genetics Knowledge Park. He has extensive experience with internationalising biotech companies and has helped a number of biotechs win business and develop partnerships overseas. Commenting on the appointment, BNC's CEO, Dr David Sarphie said; "Since our launch last year, BNC has won a number of high value contracts to develop bionanotech solutions for a variety of organisations. This exciting period of growth meant that we needed someone with the right blend of scientific knowledge, product development experience and commercial know-how, to manage programmes and expand our new business opportunities. Mike is the perfect fit."
####
About Bio Nano Consulting (BNC)
The BNC is a specialist research and development consultancy operating in the convergent field of bionanotechnology. A joint venture of Imperial College London and University College London, the BNC is funded through the Technology Strategy Board (TSB) with additional support from the London Development Agency (LDA).
Along with its partner organisation, the National Physical Laboratory (NPL), the BNC offers a service to the biomedical and healthcare industries in microsystems and nanotechnology. This encompasses design, 3-D modelling and visualisation, rapid prototyping, and characterisation.
For more information, please click here
Contacts:
Product
Enquiries
Bio Nano Consulting
Dr David Sarphie – CEO
t: +44 (0)207 268 3032
Media enquiries
Alto Marketing Limited
Neil Ravenhill
t: +44 (0)1489 557672
Copyright © Bio Nano Consulting
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Consulting
First measurement of electron energy distributions, could enable sustainable energy technologies June 5th, 2020
Lucintel identifies and prioritizes opportunities for alumina trihydrate (ATH) fillers in the global composites industry August 3rd, 2016
Haydale Wins Major Research Grants September 26th, 2015
Silicon Valley-Based Foresight Valuation Launches STR-IP™, a New Initiative for Startups to Discover the Value of Their Intellectual Property December 18th, 2014
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||